122 filings
Page 4 of 7
8-K
hej6jqqn
8 Aug 19
Sientra Reports Second Quarter 2019 Financial Results
4:21pm
8-K
h0nsgvb
2 Jul 19
Entry into a Material Definitive Agreement
5:01pm
8-K
nc0ed
17 Jun 19
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
vlu24jm
5 Jun 19
Sientra Commences Public Offering of Common Stock
4:10pm
8-K
2gvp vm2bke
8 May 19
Sientra Reports First Quarter 2019 Financial Results
4:01pm
8-K
74q2gu4
21 Mar 19
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
4:40pm
8-K
3wjmfkh
12 Mar 19
Sientra Reports Fourth Quarter and Full Year 2018 Financial Results
4:31pm
8-K
kpq6zzwp8y7fa
7 Feb 19
Departure of Directors or Certain Officers
4:00pm
8-K
5hkkp xosm7bi8xf
7 Jan 19
Appointment of Aesthetic Industry Veteran to Board of Directors
8:30am
8-K
wjl5vgt s8cw
21 Dec 18
Departure of Directors or Certain Officers
4:30pm
8-K
26iw5ydk6vise8kyouek
6 Nov 18
Sientra Reports Third Quarter 2018 Financial Results
4:05pm
8-K
w2vvff07359wy2pl43b
19 Oct 18
Entry into a Material Definitive Agreement
8:31pm
8-K
iyymjz
20 Sep 18
Other Events
7:31am
8-K
1o8ejbb5 nih
7 Aug 18
Sientra Reports Second Quarter 2018 Financial Results
12:00am
8-K
0z69xo7eo8
3 Jul 18
Departure of Directors or Certain Officers
4:00pm
8-K
jh8tq6gilvl bd4
7 Jun 18
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
rjjwctrp
9 May 18
Sientra Reports First Quarter 2018 Financial Results
4:10pm
8-K
k9k0up 6mm
4 May 18
Sientra Commences Public Offering of Common Stock
6:07am
8-K
j1uxa2zd4rgugh6 slk
30 Apr 18
Other Events
6:46am
8-K
c4hp5 kxa51
20 Apr 18
Sientra Receives FDA Approval of PMA Supplement
12:00am